dupixent specialty pharmacy

If symptoms persist or worsen, consider rheumatological evaluation and/or discontinuation of DUPIXENT. If the patient is eligible for copay assistance, the patient or caregiver can then ensure the copay assistance is applied, coordinate delivery with the specialty pharmacy, and access additionalDUPIXENT MyWaysupport. Alternatively, call 833-203-1742 or fax the prescription to 800-378-0323. It is not known whether DUPIXENT passes into your breast milk. We can help. LIBERTY ASTHMA TRAVERSE CSR, 2020. Be proactive, take control into your hands and talk to your doctor to see if DUPIXENT is right for you. Patients can enroll in DUPIXENT MyWay by calling 1-844-DUPIXEN (T) or 1-844-387-4936 Atopic Dermatitis: The most common adverse reactions (incidence 1%) in patients are injection site reactions, conjunctivitis, blepharitis, oral herpes, keratitis, eye pruritus, other herpes simplex virus infection, dry eye, and eosinophilia. older with moderate-to-severe atopic Insightful tips and tools to help them along the way, One-on-one nursing support, when needed, to provide disease and DUPIXENT education and ongoing follow-up to ensure patients stay on track with DUPIXENT, Reminder when eligible patients must reapply for financial support programs (Copay Card Program, Patient Assistance Program), Supplemental injection training virtually or over the phone. 2023Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. therapies are not advisable. Both companies may independently process your personal data to manage patient support programs and product marketing campaigns. The DUPIXENTMyWay Copay Card may help eligible, commercially insured patients cover the out-of-pocket cost of DUPIXENT. CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (CRSwNP) Ages 18+ Years, EOSINOPHILIC ESOPHAGITIS (EoE) Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT. DUPIXENT is a prescription medicine used: Questions or comments? Fax: 1-877-222-5036. Populate the clinical information corresponding to your patients diagnosis. Monday-Friday, 8 am to 9 pm ET. Dupixent (dupilumab) Fasenra (benralizumab) Nucala (mepolizumab) Tezspire (tezepelumab-ekko) Xolair (omalizumab) - Enrollment Form Xolair (omalizumab) - Re-order Form (Existing Patients) Alpha-1 Antitrypsin Deficiency AralastNP (alpha1-proteinase inhibitor [human]) Glassia (alpha1-proteinase inhibitor [human]) Lastly, the specialty pharmacy reviews the prescription and contacts the patient to arrange for payment and delivery. In order to be effective, and work properly, biologics are injectable medicines. students and our specialty pharmacy family at the ashp midyear . as an add-on maintenance treatment 1. In children 6 to 11 years old using Dupixent or placebo plus a topical corticosteroid for severe eczema, studies at 16 weeks show that . Sanofi US is hosting this website on behalf of Sanofi and Regeneron Pharmaceuticals, Inc. A list of potential codes is provided within the Enrollment Form for reference. Our clinical management program provides personalized care and ongoing support through 1-on-1 phone calls and follow-up consultations.Learn more. In some denial cases, a plan may require a peer-to-peer review with a medical reviewer at the health plan. Your doctor will tell you if you are able to self-inject (if so, training by the HCP will be provided), how much DUPIXENT to inject, and how often to inject it. Its important to understand how to identify prescription drug coverage. All Rights Reserved. 2350 Three Mile Road NW. to contact DUPIXENT MyWay. Fax the Enrollment Form with the checked box to both the specialty pharmacy and DUPIXENT MyWay. Both companies may independently process your personal data to manage patient support programs and product marketing campaigns. Limitation of Use: DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus. Dupixent calms an overreactive immune system but does not suppress the immune system. DUPIXENT andDUPIXENT MyWayare registered trademarks of Sanofi Biotechnology. The DUPIXENT 200 mg and It is also considered a specialty drug, and it may require special approval from your insurance company. DUPIXENT can be used with or without topical corticosteroids. You can help by directing them to theDUPIXENT MyWayEnrollment Forms below. has not been definitively ECZEMA (Atopic Dermatitis or AD) Ages 6+ Months, Add-on Maintenance Treatment for Uncontrolled Moderate-to-Severe Eosinophilic or Oral Steroid Dependent weighing at least 40 kg, and older They will also help you and your patient understand the appeals process if coverage is denied. Conjunctivitis and keratitis have been reported with DUPIXENT in postmarketing settings, predominantly in AD patients. Get emergency medical help if you have signs of an allergic reaction to Dupixent: hives, rash, itching; fever, swollen glands, joint pain; feeling light-headed, difficult breathing; swelling of your face, lips, tongue, or throat. Nasal Polyposis (CRSwNP): Benefits Investigation, Prior Authorization (PA), and Appeals Support. years and older with Please see accompanying adjacent links for full Prescribing Information including Patient Information. Key points of contact for coverage are located on the card itself. Advising the patient to contact the specialty pharmacy for preferred delivery location. Certain specialty medication may not qualify. Helminth infections (5 cases of enterobiasis and 1 case of ascariasis) were reported in pediatric patients 6 to 11 years old in the pediatric asthma development program. DUPIXENT MyWayrepresentative arranges shipment with patient via specialty pharmacy (in network) or patient arranges shipment with specialty pharmacy (out of network). moderate-to-severe asthma DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. Eosinophilic Esophagitis: DUPIXENT is indicated for the treatment of adult and pediatric patients aged 12 years and older, weighing at least 40 kg, with eosinophilic esophagitis (EoE). Explore our comprehensive guides and video resources for more information regarding your condition. Please call THERACOM INC at (888) 843-7226 to . DUPIXENT can be used with or without topical corticosteroids. These events may be associated with the reduction of oral corticosteroid therapy. Be sure to check your inbox. 2023 Magellan Rx Management, LLC. Epclusa . Learn how to get your patients started with DUPIXENT MyWay. This will allow the specialty pharmacy to conduct the benefits investigation, and DUPIXENT MyWay will provide additional support to the patient. Dupixent may cause serious side effects. CoverMyMeds provides additional PA process-related support for DUPIXENT. If the patient has consented, the patients nurse educator will initiate a welcome call with the patient within a few days after enrolling. Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines; have asthma and use an asthma medicine; or have atopic dermatitis, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, or prurigo nodularis and also have asthma. If you have questions or need assistance, we're always here to help. Patients may be eligible for theDUPIXENT MyWayCopay Card if they: Send them the following link to see if they're eligible: Assistance may still be available for patients who do not have insurance. Current patient Patient's first name . We also offer infusion services with Optum Infusion Pharmacy. Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP), DUP.22.09.0186Last Update: October 2022, Chronic Rhinosinusitis with Nasal Polyposis, https://mothertobaby.org/ongoing-study/dupixent/. The Food and Drug Administration (FDA) has approved it to treat the following conditions: certain types of asthma in adults and. 3. These are not all the possible side effects of DUPIXENT. Click to skip to content. adequately controlled with topical available for your appropriate Consider ophthalmological examination for patients who develop conjunctivitis that does not resolve following standard treatment or signs and symptoms suggestive of keratitis, as appropriate. In children 6 months to less than 12 years of age, DUPIXENT should be given by a caregiver. Patients will need to meet the eligibility criteria, including household income, to qualify. Be sure to provide only one ICD-10 code, even if the patient has comorbid disease. For more information, Refill and track your specialty drug prescriptions, pay online, and get live support. Dysport. Chronic Rhinosinusitis with After you have determined DUPIXENT is appropriate for your patient and written them a prescription: Submit theDUPIXENT MyWayEnrollment Form, Submit PA and Letter of Medical Necessity (optional) and include all required documentation (a copy of your chart notes with details of diagnosis, disease severity, and treatment history), Receive status updates from yourDUPIXENT MyWayCoordinator. Prurigo Nodularis: Contact Sanofi USor call1-844-643-7346 Learn more about our available resources to help navigate the insurance process. Since DUPIXENT is a specialty medication, it may require additional approval from your insurance company and is typically shipped from a specialty pharmacy. LimitationofUse: option 1 4. Contact your Field Access Specialist or callDUPIXENT MyWayat1-844-387-4936, Monday through Friday, 8 am to 9 pm Eastern Time. Magellan Rx Specialty Pharmacy Making a difference in pharmacy care Specialty drug spend escalated dramatically over the past decade. All criteria below must be met in order . to treat adults and children 12 years of age and older, who weigh at least 88 pounds (40 kg), with eosinophilic esophagitis (EoE). Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider. You or your patients can contact Enter your email address and we will send you your personalized guide. No, Dupixent (dupilumab) is not an immunosuppressant or a steroid. Cases of eosinophilic pneumonia were reported in adult subjects who participated in the asthma development program and cases of vasculitis consistent with EGPA have been reported with DUPIXENT in adult subjects who participated in the asthma development program as well as in adult subjects with co-morbid asthma in the CRSwNP development program.

Why Did Jeremiah Brent Change His Name, Articles D